Nachrichten zur Amgen Inc. Aktie

Amgen (AMGN) Earnings Expected to Grow: Should You Buy?

Amgen (AMGN) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday

Vertex Pharmaceuticals (NASDAQ: VRTX) had a fine Tuesday on the stock exchange. The biotechs shares closed the day nearly 3%…

3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold

When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects. However,…

Amgen (AMGN) Stock Moves -1.3%: What You Should Know

Amgen (AMGN) concluded the recent trading session at $273.68, signifying a -1.3% move from its prior days close.…

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know

In the closing of the recent trading day, Amgen (AMGN) stood at $277.29, denoting a -1.89% change from the preceding…

2 Dividend Stocks Defying the Tariff-Fueled Market Correction to Buy and Hold Forever

Equities are down this year because of Donald Trumps trade policies. The 47th U.S. president decided to impose steep tariffs…

Erleichterung bei Apple, Aktie gibt wieder Gas: Das sagen jetzt Goldman Sachs & Co

Die Aktie von Apple hat am Montag zu den drei stärksten Werten im Dow Jones gezählt. Nur Amgen und Travelers…

Amgen Aktie: Kursziel angehoben

New York (www.aktiencheck.de) - Rating-Update: Terence Flynn, Analyst von Morgan Stanley, stuft die Aktie von Amgen Inc. (ISIN: US0311621009, WKN: 867900,…

Switzerland’s Sandoz files antitrust lawsuit against Amgen in US By Reuters

Switzerland’s Sandoz files antitrust lawsuit against Amgen in US…

Amgen (AMGN) Gains But Lags Market: What You Should Know

In the latest trading session, Amgen (AMGN) closed at $285.92, marking a +1.6% move from the previous day.…

Rule Breaker Investing: Essays From Yesterday, Vol. 7

Its time once again to dust off Motley Fool co-founder David Gardners old writings and pull some lessons forward into…

Amgen positioniert sich im Geschäft mit Adipositas-Medikamenten! Aktie zeigt starke Gegenreaktion nach dem Aussetzen der Zölle

Trotz stabiler Nachfrage hat das Gesundheitswesen wie der Rest des Marktes einen Rückschlag erlitten. Dieser Pharmariese könnte seine Gewinne in…

Vom Thron gestoßen: Apple im freien Fall

Die Aktie von Apple stand am Dienstag erneut massiv unter Druck. Mit einem Minus von fünf Prozent war sie noch…

4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street

As biotech investors know, companies in the industry can sometimes earn significant returns in relatively short periods, like a year,…

3 Dividend Stocks to Buy and Hold for the Next Decade

What should investors do when stocks are tanking over the short term? Probably the best answer is to think long…

2 Dividend Stocks to Buy Hand Over Fist in April

One factor that keeps some investors away from healthcare stocks is the sectors dearth of generous and reliable dividend payers.…

Amgen (AMGN) Rises As Market Takes a Dip: Key Facts

Amgen (AMGN) concluded the recent trading session at $310.09, signifying a +1.44% move from its prior days close.…

Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Markets Swoon on Thursday

As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on Wednesday decimated the…

US FDA approves expanded use of Amgens rare disease drug

The U.S. Food and Drug Administration has approved the expanded use of Amgens drug, Uplizna, to help reduce the risk…

Beat the S&P 500 With This Cash-Gushing Dividend Stock

Investors seeking relief from stock market volatility should take a closer look at Bristol Myers Squibb (NYSE: BMY). At the…

Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing

Amgen (AMGN) concluded the recent trading session at $311.55, signifying a +1.5% move from its prior days close.…

2 Surefire Dividend Stocks That Could Pay You for Life

Dividend investing is an excellent strategy for (at least) two reasons. Companies that can provide consistent payouts generally have robust…

Which Dow Jones Stock Is Cheaper, Amgen or Merck?

Four of the 30 stocks that make up the Dow Jones Industrial Average represent the healthcare sector. Within that group,…

Why Pharma and Biotech Stocks Got Thrashed on Tuesday

As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative…

Seltene Funktionsverlust-Varianten in HECTD2 und AKAP11 bergen ein Risiko für bipolare Störung

deCODE genetics: Reykjavik, Island, 25. März 2025 (ots/PRNewswire) - Wissenschaftler von deCODE genetics, einer Tochtergesellschaft von Amgen, zeigen heute in…

Nasdaq Correction: Was It a Mistake to Add Nvidia, Amazon, and Salesforce to The Dow Jones Industrial Average?

The Dow Jones Industrial Average (DJINDICES: ^DJI) has changed a lot in recent years. In 2020, Salesforce, Amgen, and Honeywell…

Amgen (AMGN) Stock Drops Despite Market Gains: Important Facts to Note

In the latest trading session, Amgen (AMGN) closed at $314.38, marking a -0.53% move from the previous day.…

Why Amgen (AMGN) is a Top Value Stock for the Long-Term

Whether youre a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top…

Amgen outlook revised to positive by Fitch, ratings affirmed By Investing.com

Amgen outlook revised to positive by Fitch, ratings affirmed…

FDA Accepts RDY & ALVOs Prolia & Xgeva Biosimilar BLA for Review

Dr. Reddy and Alvotech announce the FDA acceptance of the BLA for their proposed biosimilar candidate of Amgens Prolia and…

Why the Market Dipped But Amgen (AMGN) Gained Today

Amgen (AMGN) concluded the recent trading session at $318.65, signifying a +0.47% move from its prior days close.…

Amgen Rises Almost 22% YTD: Should You Buy, Hold or Sell the Stock?

AMGNs consistent top-line growth, an interesting pipeline and rising estimates are good enough reasons to stay invested in the stock…

Prediction: These 2 Stocks Will Outperform the Market Through 2030

Equity markets can move every which way from one day to the next. The more we extend our horizon, the…

Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider

The latest trading day saw Amgen (AMGN) settling at $317.17, representing a +1.1% change from its previous close.…

5 Reasons the Schwab U.S. Dividend Equity ETF Is a Long-Term Buy for 2030 and Beyond

Lets say you have some money in your pocket you want to invest, but youre not sure where to put…

Motley Fool Market Cap Showdown: Bill Barker vs. Emily Flippen

Its time for another round of The Market Cap Game Show on Rule Breaker Investing. Remember that market cap calculates…

Amgen Aktie: Gewinn mit Weitsicht!

Der führende Biotechnologiekonzern Amgen steht aktuell an einem entscheidenden Punkt, während die Finanzmärkte mit Unsicherheiten kämpfen. Der Aktienkurs des Unternehmens…

Is Eli Lilly Stock a Buy?

Like many pharma stocks, Eli Lilly (NYSE: LLY) offers investors a bit of safety -- and its an element you…

Amgen: Nächste gute Nachricht – AKTIONÄR-Tipp 32 Prozent im Plus

In der jüngeren Vergangenheit konnte Amgen mit verheißungsvollen News zu einem Adipositas-Medikament und einer Dividenden-Erhöhung glänzen (DER AKTIONÄR berichtete). Am…

Amgen Aktie weiter stark - Phase-3-Erfolg und starke Pipeline beflügeln

Kulmbach (www.aktiencheck.de) - Amgen-Aktienanalyse von "Der Aktionär": Martin Mrowka vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Amgen Inc. (ISIN: US0311621009,…

AMGNs Eczema Drug Meets Goal in Two Late-Stage Studies

Data from two more late-stage studies show that treatment with Amgens rocatinlimab improves outcomes in atopic dermatitis indication.…

Take the Zacks Approach to Beat the Markets: NioCorp, AngloGold, Amgen in Focus

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the…

1 Dividend Stock Down 30% to Buy and Hold for the Next Decade

Biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) saw its fortunes reversed last year. Though the drugmaker had performed well since the…

3 Magnificent Growth Stocks to Buy in March

Its often challenging to decide which stocks to invest in. However, some companies look too attractive to pass up. We…

2 Dividend Stocks to Buy for a Lifetime of Passive Income

Dividend investors dont buy shares of companies hoping they will suspend their payouts soon. The longer a corporation maintains its…

Amgen (AMGN) Up 2.9% Since Last Earnings Report: Can It Continue?

Amgen (AMGN) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

AMGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Amgen Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Amgen starts two critical late-stage trials for weight loss drug MariTide

MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and Eli…

Prediction: 2 Brilliant Vanguard Index Funds Will Continue to Beat the S&P 500 in 2025

The S&P 500 (SNPINDEX: ^GSPC) is widely considered the best gauge for the overall U.S. stock market due to its…

This Could Be the Best GLP-1 Stock to Buy in 2025

The GLP-1 weight loss market is a massive one, with some analysts expecting it to be worth around $200 billion…